Corrigendum

  • The EMBO Journal (2008) 27, 1421
  • doi:10.1038/emboj.2008.91

NF-kappaB dictates the degradation pathway of IkappaBalpha

Erika Mathes, Ellen L O'Dea, Alexander Hoffmann and Gourisankar Ghosh


Correction to:The EMBO Journal, advance online publication 10 April 2008; doi:10.1038/emboj.2008.73


Since the publication of this paper, the authors have noticed an error in Figure 2B. The X-axis should have been labelled in hours and not minutes.

Figure 1.

Figure 1 :

NF-kappaB determines the degradation pathway of IkappaBalpha. (A) NF-kappaB protects IkappaBalpha from proteasomal degradation in vitro. Top: purified 20S proteasome and IkappaBalpha were incubated at 37°C, with or without purified p65. (I) represents the proteasome inhibitor MG132. (B) IkappaBalpha is highly stable in vivo in the presence of NF-kappaB. Left panel: WB showing WT, IKK phosphorylation and ubiquitination-defective mutants introduced into ikba-/-, where all NF-kappaB subunits are present. Cells were treated with cycloheximide (CHX) for different lengths of time (up to 24 h) and the protein levels were visualized by WB. Right panel: this experiment was repeated twice and is represented graphically with error bars signifying plusminuss.e.m. (circle) Transgenic WT IkappaBalpha, (square) K21, 22R IkappaBalpha, (triangle) KR9 IkappaBalpha and (diamond) S32, 36A IkappaBalpha. (C) A model of NF-kappaB repression by IkappaBalpha in pre-stimulated cells. There are two processes that control IkappaBalpha degradation. In the resting cell, basal IKK activity phosphorylates bound IkappaBalpha and targets it for ubiquitin-dependent degradation. In addition, free IkappaBalpha is continuously synthesized and degraded in an IKK- and Ub-independent mechanism. This keeps NF-kappaB from being activated in the resting cell.

View full figure (108 KB)

The correct Figure 2 is shown below.

The authors apologize for any inconvenience caused.



Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

REVIEWS

Oestrogen as a neuroprotective hormone

Nature Reviews Neuroscience Review (01 Jun 2002)

Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein

Nature Reviews Neuroscience Review (01 Dec 2002)